MacroGenics (NASDAQ: MGNX) Stock Crashes Amidst Tragic Cancer Drug Trial Results
MacroGenics (NASDAQ: MGNX) stock plummeted about 80% in intraday trading Friday following reports of multiple fatalities and over 50% of […]
MacroGenics (NASDAQ: MGNX) Stock Crashes Amidst Tragic Cancer Drug Trial Results Read More »